Navigation Links
EMPHASIS HF: Study shows epleronone to reduce atrial fibrillation
Date:5/22/2011

May 22, 2011- Gothenburg, Sweden : The aldosterone antagonist eplerenone (Inspra, Pfizer) significantly reduced the development of new onset atrial fibrillation and flutter (AFF) in patients with class 2 heart failure, concludes a sub-analysis of the EMPHASIS-HF trial, presented at the Heart Failure Congress 2011, organized by the Heart Failure Association of the European Society of Cardiology (ESC). The analysis, presented in Late Breaking Session 1, furthermore showed that the beneficial effects of eplerenone in reducing major CV events were similar in patients with and without AFF at the start of the study.

The Eplerenone in Mild Patients Hospitalization And Survival Study in Heart Failure study (EMPHASIS-HF) - presented first at the American Heart Association Meeting in 2010 and published simultaneously on-line in the New England Journal of Medicine - showed that eplerenone in comparison to placebo produced a 37% reduction in the primary end point of the composite of death from cardiovascular causes or hospitalization for heart failure, a 24% reduction in cardiovascular death, and a 42% reduction in hospitalization for heart failure for patients with class 2 heart failure.

While previous studies had shown that aldosterone blockade delivered significant benefits in patients with class 3-4 heart failure (The RALES study) or in post MI patients with left ventricular dysfunction (The EPHESUS study), what had been unknown until EMPHASIS-HF was whether the benefits could be extended to the far larger population of patients with mild heart failure (class1-2). The RALES study used spironolactone, while the EPHESUS study used the newer, more selective eplerenone.

The EMPHASIS-HF trial - which involved 2737 patients from 278 centres with NYHA class 2 heart failure and ejection fractions of no more than 35% - set out to address the question of whether eplerenone was effective in patients with mild heart failure. Patients were randomized
'/>"/>

Contact: Jacqueline Partarrieu
press@escardio.org
33-492-947-756
European Society of Cardiology
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Social marketing in public health conference adds emphasis on environmental issues
2. Robotic Surgery Oversold on Hospital Websites, Study Contends
3. Driving Skills Do Ebb With Age: Study
4. Study Sees Link Between Psoriasis, Obesity in Kids
5. Study Suggests Supplement May Protect Against Preeclampsia
6. Enlarged prostate: Study demonstrates immediate and long-term benefits of laser treatment
7. NIH awards Salk Institute $5.5 million grant to study Williams syndrome
8. Punches Land Harder When Delivered From Above: Study
9. Mammals Brains Grew Larger to Enhance Sense of Smell: Study
10. Many Women Can Have Cervical Cancer Test Every 3 Years: Study
11. Curcumin compound improves effectiveness of head and neck cancer treatment, U-M study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... in benign prostate tissue was associated with high-grade, ... found even in those with low prostate-specific antigen ... Cancer Epidemiology, Biomarkers & Prevention , a ... , An analysis of prostate tissue biopsies collected ... the Prostate Cancer Prevention Trial (PCPT) found that ...
(Date:4/17/2014)... CHAMPAIGN, Ill. One of the most popular vaccine ... choice. And doctors may be overlooking some cost factors ... actually a more expensive option, according to a new ... of vaccines to administer can be driven by numerous ... study and a professor of computer science and of ...
(Date:4/17/2014)... AURORA, Colo. (April 17, 2014) Two recent ... Medicine researcher and colleagues may help scientists develop ... virus, Yellow fever, Japanese encephalitis and other disease-causing ... of biochemistry and molecular genetics at the School ... the Howard Hughes Medical Institute, and colleagues recently ...
(Date:4/17/2014)... Rochelle, NY, April 17, 2014U.S. military personnel who ... plus impact" concussive traumatic brain injury (TBI) were ... evacuated for other medical reasons. Differences in measures ... depression 6-12 months after injury are reported in ... a peer-reviewed journal from Mary Ann Liebert, Inc., ...
(Date:4/17/2014)... one in five infants in the United States annually ... several months after birth. Research into probiotic use for ... April 1, 2014 issue of the British Medical ... "Probiotics and Infant Colic," concluding that the use of ... did not reduce crying or fussing in infants ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study recalculates costs of combination vaccines 2Health News:CU researchers discover target for treating dengue fever 2Health News:Long-term effects of battle-related 'blast plus impact' concussive TBI in US military 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... Vancouver Residents in cardiac surgery who receive extra training ... get into the operating room, Dr. Buu-Khanh Lam today told ... Stroke Foundation and the Canadian Cardiovascular Society. Dr. ... containing sutures, forceps, and miniature tubing that can be ...
... FRIDAY, Oct. 21 (HealthDay News) -- ,Children with specific ... Concerta), which is widely used to treat attention-deficit hyperactivity ... could help improve treatment of ADHD, according to the ... have a good way of predicting who will experience ...
... at the University of Utah have discovered a new way ... tools for predicting which breast cancers will spread and new ... results are published online today in the journal Nature ... cancer studies, the researchers grafted tumor tissue from consenting breast ...
... blood pressure, improve lifestyle and enhance quality of life, ... "E-counselling has the potential to strengthen ... Dr. Nolan told the Canadian Cardiovascular Congress, which is ... Canadian Cardiovascular Society. "We found that it led to ...
... risk factors for hepatocellular cancer, smoking, obesity, and heavy alcohol ... to a large share of the disease burden in Europe, ... the Journal of the National Cancer Institute. ... C and hepatocellular cancer has been known for a few ...
... , FRIDAY, Oct. 21 (HealthDay News) --,Older ... outpatient surgery and receiving a short-acting anesthetic, according to ... driving abilities were tested on a driving simulator before ... under sedation. The researchers looked at the participants, degree ...
Cached Medicine News:Health News:Heart surgeons-in-training benefit from hands-on homework 2Health News:Some Kids Respond Better to ADHD Drug Than Others 2Health News:Will my breast cancer spread? Discovery may predict probability of metastasis 2Health News:E-counselling shows dramatic results in lowering blood pressure 2Health News:E-counselling shows dramatic results in lowering blood pressure 3Health News:European studies on risks of hepatocellular carcinoma 2Health News:European studies on risks of hepatocellular carcinoma 3Health News:Older Drivers More Cautious Than Younger Ones After Surgery 2
(Date:1/15/2014)... , Jan. 15, 2014  A novel wearable injector slightly larger ... painless for patients to self-inject prescription drugs in the large ... cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... to $220B by 2018, according to analysts.   Many of these ...
(Date:1/14/2014)...  Luminex Corporation (Nasdaq: LMNX ) today announced that ... 2013 on Monday, February 3, 2014. A press release announcing ... trading. (Logo: http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) ... highlights and financial results for the fourth quarter and twelve ...
(Date:1/14/2014)... Calif. , Jan. 14, 2014 The Brandeis Medical Center, ... Angeles a premier and affordable laser tattoo removal experience ... Dr. Brandeis, focus is in providing high quality cosmetic services with ... patients. " Southern California has seen ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
... QPT: TSX Venture Exchange, EDMONTON, May 02, 2007 ... Quest is pleased to provide an,update on the ... cancer. , Prostate cancer is the second leading ... 230,000 new cases and 30,000 deaths,per year. Current ...
... Mass.--(BUSINESS WIRE)--May 3, 2007 - Xanthus,Pharmaceuticals, Inc ... clinical and pathological signs of chronic,disease in ... presentation,was made by Stephen J. Karlik, Ph.D., ... Western Ontario, London, Ontario,together with researchers from ...
Cached Medicine Technology:Quest PharmaTech's Prostate Cancer Program Update 2Quest PharmaTech's Prostate Cancer Program Update 3Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 2Xanthus Presents Novel Approach for Autoimmune Disease Reversal,with Symadex 3
... MICROSTAAR injector contains a plunger style advance, ... be resterilized for multiple use. The injector ... accepts only STAAR cartridges. These injectors are ... This system was designed specifically ...
... the fundamental capsulotmy laser - the unique Ultra ... 2855% less energy in air at approximately 1.8 ... This technology eliminates the occurrence of hot ... pitting. , , , Ultra Q ...
... system is an innovative, robust and ... excellent clinical performance. The digital broadband ... the ES500 system deliver excellent tissue ... system offers a full suite of ...
Protects the eye during or after surgery or trauma. 8mm diameter, lint free keeps cornea moist. Protects retina from operating microscope light rays....
Medicine Products: